Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315428897> ?p ?o ?g. }
- W2315428897 endingPage "162" @default.
- W2315428897 startingPage "159" @default.
- W2315428897 abstract "Efficacy signals but substantial myelosuppression were demonstrated in a single arm phase II study of paclitaxel poliglumex (PPX) in combination with temozolomide (TMZ) and radiation therapy (RT) for first-line treatment of glioblastoma. The objective of this randomized phase II trial was to assess the efficacy and safety of single-agent PPX with RT (PPX/RT) versus TMZ with RT (TMZ/RT) for glioblastoma without O-methylguanine-DNA methyltransferase (MGMT) methylation.Patients with glioblastoma with unmethylated MGMT without prior chemotherapy or RT were eligible. Patients were randomly assigned 2:1 to PPX, 50 mg/m/wk for 6 weeks, or standard TMZ, with concurrent 60.0 Gy RT. One month after completion of chemoradiation all patients received standard maintenance TMZ. The primary endpoint was progression-free survival (PFS).Of the 164 patients enrolled, 86 were MGMT unmethylated. Of these, 63 patients were randomized (42 to PPX/RT and 21 to TMZ/RT). Fifty-nine patients could be analyzed. The median PFS was 9 months in the PPX/RT group and 9.5 months in the TMZ/RT group (hazard ratio in the PPX/RT group, 1.10; 95% confidence interval, 0.79-2.08; P=0.75). Median overall survival was 16 versus 14.8 months for PPX/RT and TMZ/RT groups, respectively (hazard ratio, 1.44; 95% confidence interval, 0.75-2.77; P=0.27). In the PPX and TMZ groups 44% versus 22% of patients, respectively, experienced one or more grade 3 or higher toxicities during chemoradiation.PPX/RT did not improve PFS or overall survival. This study provides an effective trial design for screening RT sensitizers in glioblastoma." @default.
- W2315428897 created "2016-06-24" @default.
- W2315428897 creator A5002584169 @default.
- W2315428897 creator A5005854046 @default.
- W2315428897 creator A5008810869 @default.
- W2315428897 creator A5013039829 @default.
- W2315428897 creator A5014909652 @default.
- W2315428897 creator A5016147983 @default.
- W2315428897 creator A5022455642 @default.
- W2315428897 creator A5032503170 @default.
- W2315428897 creator A5046827333 @default.
- W2315428897 creator A5050392689 @default.
- W2315428897 creator A5058794118 @default.
- W2315428897 creator A5062289529 @default.
- W2315428897 creator A5062905847 @default.
- W2315428897 creator A5063863193 @default.
- W2315428897 creator A5064704860 @default.
- W2315428897 creator A5070567202 @default.
- W2315428897 creator A5071882573 @default.
- W2315428897 creator A5082169122 @default.
- W2315428897 creator A5084116070 @default.
- W2315428897 date "2018-02-01" @default.
- W2315428897 modified "2023-10-16" @default.
- W2315428897 title "PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation" @default.
- W2315428897 cites W1970695401 @default.
- W2315428897 cites W2000584529 @default.
- W2315428897 cites W2036044314 @default.
- W2315428897 cites W2064779136 @default.
- W2315428897 cites W2076307753 @default.
- W2315428897 cites W2096287682 @default.
- W2315428897 cites W2105100844 @default.
- W2315428897 cites W2124736921 @default.
- W2315428897 cites W2345170456 @default.
- W2315428897 doi "https://doi.org/10.1097/coc.0000000000000247" @default.
- W2315428897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26658237" @default.
- W2315428897 hasPublicationYear "2018" @default.
- W2315428897 type Work @default.
- W2315428897 sameAs 2315428897 @default.
- W2315428897 citedByCount "12" @default.
- W2315428897 countsByYear W23154288972016 @default.
- W2315428897 countsByYear W23154288972019 @default.
- W2315428897 countsByYear W23154288972020 @default.
- W2315428897 countsByYear W23154288972021 @default.
- W2315428897 countsByYear W23154288972022 @default.
- W2315428897 crossrefType "journal-article" @default.
- W2315428897 hasAuthorship W2315428897A5002584169 @default.
- W2315428897 hasAuthorship W2315428897A5005854046 @default.
- W2315428897 hasAuthorship W2315428897A5008810869 @default.
- W2315428897 hasAuthorship W2315428897A5013039829 @default.
- W2315428897 hasAuthorship W2315428897A5014909652 @default.
- W2315428897 hasAuthorship W2315428897A5016147983 @default.
- W2315428897 hasAuthorship W2315428897A5022455642 @default.
- W2315428897 hasAuthorship W2315428897A5032503170 @default.
- W2315428897 hasAuthorship W2315428897A5046827333 @default.
- W2315428897 hasAuthorship W2315428897A5050392689 @default.
- W2315428897 hasAuthorship W2315428897A5058794118 @default.
- W2315428897 hasAuthorship W2315428897A5062289529 @default.
- W2315428897 hasAuthorship W2315428897A5062905847 @default.
- W2315428897 hasAuthorship W2315428897A5063863193 @default.
- W2315428897 hasAuthorship W2315428897A5064704860 @default.
- W2315428897 hasAuthorship W2315428897A5070567202 @default.
- W2315428897 hasAuthorship W2315428897A5071882573 @default.
- W2315428897 hasAuthorship W2315428897A5082169122 @default.
- W2315428897 hasAuthorship W2315428897A5084116070 @default.
- W2315428897 hasConcept C104317684 @default.
- W2315428897 hasConcept C126322002 @default.
- W2315428897 hasConcept C143998085 @default.
- W2315428897 hasConcept C168563851 @default.
- W2315428897 hasConcept C203092338 @default.
- W2315428897 hasConcept C207103383 @default.
- W2315428897 hasConcept C2776694085 @default.
- W2315428897 hasConcept C2777389519 @default.
- W2315428897 hasConcept C2780739268 @default.
- W2315428897 hasConcept C33288867 @default.
- W2315428897 hasConcept C44249647 @default.
- W2315428897 hasConcept C55493867 @default.
- W2315428897 hasConcept C71924100 @default.
- W2315428897 hasConcept C86803240 @default.
- W2315428897 hasConcept C90924648 @default.
- W2315428897 hasConcept C91965660 @default.
- W2315428897 hasConceptScore W2315428897C104317684 @default.
- W2315428897 hasConceptScore W2315428897C126322002 @default.
- W2315428897 hasConceptScore W2315428897C143998085 @default.
- W2315428897 hasConceptScore W2315428897C168563851 @default.
- W2315428897 hasConceptScore W2315428897C203092338 @default.
- W2315428897 hasConceptScore W2315428897C207103383 @default.
- W2315428897 hasConceptScore W2315428897C2776694085 @default.
- W2315428897 hasConceptScore W2315428897C2777389519 @default.
- W2315428897 hasConceptScore W2315428897C2780739268 @default.
- W2315428897 hasConceptScore W2315428897C33288867 @default.
- W2315428897 hasConceptScore W2315428897C44249647 @default.
- W2315428897 hasConceptScore W2315428897C55493867 @default.
- W2315428897 hasConceptScore W2315428897C71924100 @default.
- W2315428897 hasConceptScore W2315428897C86803240 @default.
- W2315428897 hasConceptScore W2315428897C90924648 @default.
- W2315428897 hasConceptScore W2315428897C91965660 @default.
- W2315428897 hasIssue "2" @default.
- W2315428897 hasLocation W23154288971 @default.